Bolt BiotherapeuticsBOLT
13F holders, Q2 2024 (June 30)At the end of Q2 2024, 37 institutions reported holding Bolt Biotherapeutics Inc. (BOLT) in their 13F filings, down 2 from Q1 2024. 4 opened new positions and 6 sold out. The largest holders were Tang Capital Management LLC ($2.9M), Vivo Capital, LLC ($2.6M) and Sofinnova Investments, Inc. ($2.1M). 2 famous investors held it, including Ken Griffin (0.0% of Citadel Advisors's portfolio) and Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Bolt Biotherapeutics Inc.
- CUSIP
- 097702104
- Latest filing quarter
- Q1 2025
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $75K |
| Exits | 6 | $2.4M |
All 13F filers, Q1 2024 → Q2 2024: 971,009 shares bought and 2,346,304 shares sold, net −1,375,295 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 37 holders
| Tang Capital Management LLC | 0.29% | Add +11.5% | 3,812,773 | $2.9M |
| Vivo Capital, LLC | 0.24% | No change | 3,521,291 | $2.6M |
| Sofinnova Investments, Inc. | 0.13% | No change | 2,754,437 | $2.1M |
| Citadel Advisors | 0.00% | Reduce -2.0% | 2,367,511 | $1.8M |
| Pivotal bioVenture Partners Investment Advisor LLC | 1.09% | No change | 1,891,467 | $1.4M |
| Newtyn Management, LLC | 0.19% | Reduce -19.8% | 1,363,234 | $1.0M |
| Nan Fung Group Holdings Ltd | 0.93% | No change | 1,166,952 | $875K |
| Vanguard Group Inc. | 0.00% | Add +2.9% | 1,067,405 | $801K |
| Samsara Biocapital, LLC | 0.16% | No change | 1,049,153 | $787K |
| Board of Trustees of The Leland Stanford Junior University | 0.04% | No change | 719,546 | $540K |
| Acuitas Investments, LLC | 0.25% | Add +21.7% | 630,507 | $473K |
| Adage Capital Partners Gp, L.L.C. | 0.00% | No change | 500,000 | $375K |
| Geode Capital Management, LLC | 0.00% | Add +6.7% | 370,790 | $278K |
| Renaissance Technologies | 0.00% | Reduce -46.5% | 276,739 | $208K |
| BlackRock Inc. | 0.00% | Add +4.8% | 267,068 | $200K |
| ADAR1 Capital Management, LLC | 0.03% | Add +3620.0% | 185,999 | $139K |
| Marquette Asset Management, LLC | 0.01% | Add +17.7% | 113,797 | $85K |
| FMR LLC | 0.00% | Add +9.8% | 86,613 | $65K |
| Bridgeway Capital Management, LLC | 0.00% | Reduce -23.4% | 85,200 | $64K |
| Prudential Financial Inc. | 0.00% | Add +54.5% | 54,400 | $41K |
| Two Sigma Securities, LLC | 0.00% | Add +126.3% | 53,886 | $40K |
| UBS Group AG | 0.00% | Add +301.2% | 48,825 | $37K |
| State Street Corp. | 0.00% | No change | 47,437 | $36K |
| Jane Street Group, LLC | 0.00% | New | 41,528 | $31K |
| Northern Trust Corp. | 0.00% | Reduce -0.3% | 40,895 | $31K |
| Assenagon Asset Management S.A. | 0.00% | New | 34,488 | $26K |
| Morgan Stanley | 0.00% | Add +36.5% | 33,687 | $25K |
| Susquehanna International Group, LLP | 0.00% | New | 22,410 | $17K |
| Osaic Holdings, Inc. | 0.00% | No change | 15,000 | $11K |
| Steward Partners Investment Advisory, LLC | 0.00% | New | 1,000 | $750 |
| JPMorgan Chase & Co. | 0.00% | No change | 840 | $630 |
| Bank of America Corp. | 0.00% | No change | 628 | $471 |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -96.7% | 184 | $138 |
| Barclays PLC | 0.00% | No change | 139 | $104 |
| Salem Investment Counselors Inc. | 0.00% | No change | 40 | $30 |
| Qube Research & Technologies Ltd | 0.00% | No change | 2 | $2 |
| Royal Bank of Canada | 0.00% | Add +35700.0% | 358 | $0 |
"% of holder's portfolio" is BOLT's weight in each manager's 13F, not the share of Bolt Biotherapeutics Inc. the manager owns.